Re-Interpretation of PAM50 Gene Expression as Quantitative Tumor Dimensions Shows Utility for Clinical Trials: Application to Prognosis and Response to Paclitaxel in Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-018-05097-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Methods for Gene Expression Profiling in Clinical Trials for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Gene Expression Profiling for Prognosis of Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2007English

Methods for Gene Expression Profiling in Clinical Trials of Adjuvant Breast Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Tumor P16INK4 Gene Expression and Prognosis in Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Association of High Obesity With PAM50 Breast Cancer Intrinsic Subtypes and Gene Expression

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Clinical Application of Circulating Tumor Cells in Breast Cancer: Overview of the Current Interventional Trials

Cancer and Metastasis Reviews
Cancer ResearchOncology
2012English

Response to Preoperative Radiotherapy in Relation to Gene Expression Patterns in Breast Cancer Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2020English

Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Patient Barriers to Participation in Breast Cancer Clinical Trials

Breast Cancer Management
OncologyRadiologyNuclear MedicineImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy